Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Praxis Precision Medicines granted inducement RSU awards covering an aggregate of 3,478 shares to fourteen new non-executive employees on October 1, 2026. The grants were made under the 2024 Inducement Plan pursuant to Nasdaq Listing Rule 5635(c)(4) and will vest in four equal annual installments.
Key figures
- Vesting
- four equal annual installments
- Rsu shares granted
- 3478
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.